SpyGlass Pharma, Inc. (SGP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2024: -$27.06M2025: -$41.45M-$41.45M
2024Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$41.45M-53.2%
2024-$27.06M